AI in Medical Insights: From Implementation to Impact in Medical Affairs
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.
The objective is to illustrate how determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process.
Digital Science held a roundtable discussion with Medical Affairs leaders in Madrid in May 2024 on the topic of scientific communications strategies assessment and their success measurements for multiple stakeholders.
This article addresses the metrics that Medical Affairs can use to measure how effectively they communicate on their strategic imperatives, with a specific focus on Share of Scientific Voice (SoSV).
Share of Voice used to be a numbers game to increase sales and market share. But with the advent of the digital age, Share of Voice has come to mean more than just numbers.
In this podcast, we explore now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact…what’s holding us back?
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.